Glucotrack (GCTK) Cost of Revenue (2024 - 2025)
Glucotrack (GCTK) posted Cost of Revenue of $120000.0 for Q3 2025, down 34.07% on a QoQ basis from $182000.0 in Q2 2025, and down 4.0% year-over-year from $125000.0 in Q3 2024.
Glucotrack (GCTK) Cost of Revenue (2024 - 2025) Analysis & Trends
Glucotrack's Cost of Revenue history runs 2 years deep, the most recent figure standing at $120000.0 for Q3 2025.
- Quarterly Cost of Revenue fell 4.0% year-over-year to $120000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $527000.0 (changed N/A YoY) and the FY2020 annual result came in at $73000.0, down 24.74% from the prior year.
- Cost of Revenue was $120000.0 for Q3 2025 at Glucotrack, down from $182000.0 in the prior quarter.
- Across five years, Cost of Revenue topped out at $182000.0 in Q2 2025 and bottomed at $100000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 931.90 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | 2.56 Bn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 18.00 Mn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 5.51 Bn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 532.58 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 543.10 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | 11.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 346.10 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 303.50 Mn |
| 10 | Glucotrack | 186,390.31 | -7.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 120,000.00 |
| Sep 30, 2025 | 120,000.00 |
| Jun 30, 2025 | 182,000.00 |
| Jun 30, 2025 | 182,000.00 |
| Sep 30, 2024 | 125,000.00 |
| Sep 30, 2024 | 125,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |